bw 12c79 has been researched along with Hypoxia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bleehen, NM; Dixon, AK; Falk, SJ; Miles, K; Ramsay, JR; Ward, R | 1 |
Beuzard, Y; Chrétien, N; De Paepe, ME; Hoang, T; Jacmain, J; Saadane, N; Sorette, M; Trudel, M | 1 |
1 trial(s) available for bw 12c79 and Hypoxia
Article | Year |
---|---|
BW12C perturbs normal and tumour tissue oxygenation and blood flow in man.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzaldehydes; Cohort Studies; Erythrocytes; Gastrointestinal Neoplasms; Hemoglobins; Humans; Hypoxia; Laser-Doppler Flowmetry; Mitomycin; Muscle, Skeletal; Oxygen; Oxygen Consumption; Oxyhemoglobins; Regional Blood Flow; Skin; Tomography, X-Ray Computed | 1994 |
1 other study(ies) available for bw 12c79 and Hypoxia
Article | Year |
---|---|
Sickle cell disease of transgenic SAD mice.
Topics: Anemia, Sickle Cell; Animals; Antisickling Agents; Benzaldehydes; Disease Models, Animal; Erythrocytes, Abnormal; Erythropoiesis; Hypoxia; Longevity; Lung; Mice; Mice, Transgenic; Microcirculation; Spleen | 1994 |